Zakrzewski Joseph S 4
4 · AN2 Therapeutics, Inc. · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Zakrzewski Joseph S
Director
Transactions
- Sale
Common Stock
2024-01-18$19.11/sh−100,000$1,911,410→ 405,880 total(indirect: See footnote)
Holdings
- 98,199
Common Stock
Footnotes (1)
- [F1]These shares are held by Z3 Trust, for which the Reporting Person is a trustee.